synapse.patsnap.com

• charset: utf-8
• name: description content: Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and integrated R&D intelligence through artificial intelligence technologies such as natural language processing and machine learning. It empowers global pharmaceutical innovation.
• name: keywords content: Synapse, Drug Intelligence, Database
• name: viewport content: width=device-width, initial-scale=1, maximum-scale=1
• property: og:title content: Synapse - Global Drug Intelligence Database
• property: og:description content: Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and integrated R&D intelligence through artificial intelligence technologies such as natural language processing and machine learning. It empowers global pharmaceutical innovation.
• property: og:type content: website
• property: og:image content: https://synapse-static.patsnap.com/static/synapse-logo-us.png
• property: og:url content: https://synapse.patsnap.com
• property: twitter:card content: summary
• name: twitter:title content: Synapse - Global Drug Intelligence Database
• name: twitter:description content: Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and integrated R&D intelligence through artificial intelligence technologies such as natural language processing and machine learning. It empowers global pharmaceutical innovation.
• name: twitter:image content: https://synapse-static.patsnap.com/static/synapse-logo-us.png

• http://synapse.patsnap.com/plan
• Login
• http://synapse.patsnap.com/blog
• http://synapse.patsnap.com/blog/stop-drowning-in-data-meet-synapse-lens-the-ultimate-reading-assistant-for-biomed-professionals
• http://synapse.patsnap.com/blog/category/pharma_pioneer
• http://synapse.patsnap.com/blog/aqvesmes-fda-milestone-expanding-mitapivats-reach-in-thalassemia-treatment
• http://synapse.patsnap.com/blog/category/pharma_frontiers
• http://synapse.patsnap.com/blog/the-dollar4b-patent-cliff-navigating-the-generic-surge-as-astellas-xtandi-nears-expiration
• http://synapse.patsnap.com/report-list/monthly
• http://synapse.patsnap.com/report/722c9e03-fdaa-4fa9-8239-d2afceb6e739
• http://synapse.patsnap.com/report/f654f2f9-e7b5-4b0e-be46-7df0587450c1
• http://synapse.patsnap.com/report/594f73c9-ac5e-4099-8bf5-f5e4c1cb5a50
• http://synapse.patsnap.com/news
• http://synapse.patsnap.com/solution/en
• Contact us: [email protected]
• http://synapse.patsnap.com/drug-finder
• http://synapse.patsnap.com/clinical-progress-finder
• http://synapse.patsnap.com/patent-finder
• http://synapse.patsnap.com/literature-finder
• http://synapse.patsnap.com/

• https://www.prnewswire.com/news-releases/ema-validates-indication-extension-application-for-tryngolza-olezarsen-for-the-treatment-of-severe-hypertriglyceridemia-shtg-302728323.html
• https://www.prnewswire.com/news-releases/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration-302727863.html
• https://www.businesswire.com/news/home/20260330460675/en/KalVista-Pharmaceuticals-Announces-Positive-Interim-Phase-3-Data-From-KONFIDENT-KID-Trial-of-EKTERLY-sebetralstat-for-Children-Aged-2-11-Years-at-the-2026-Global-Angioedema-Leadership-Conference
• https://www.globenewswire.com/NewsRoom/ReleaseNg/7506620
• https://bio.patsnap.com/landing.html?promotion_plan=synapse_tour
• https://chemical.patsnap.com/landing.html?promotion_plan=synapse_tour
• https://www.facebook.com/PatSnapLS/
• https://www.linkedin.com/company/patsnapls/mycompany/?viewAsMember=true
• https://twitter.com/patsnapls?s=21
• https://www.youtube.com/@PatsnapWest
• https://www.patsnap.com/legal/
• https://www.patsnap.com/legal/privacy-policy/
• https://www.patsnap.com/legal/patsnap-limited-modern-slavery-act-transparency-statement/

            Domain Name: PATSNAP.COM
Registrar: DreamHost, LLC
Domain Status: client transfer prohibited
Creation Date: 2006-11-06T23:58:35Z
Registry Expiry Date: 2027-11-06T23:58:35Z
Updated Date: 2026-02-14T01:58:54Z
Name Server: NS-1304.AWSDNS-35.ORG
Name Server: NS-1574.AWSDNS-04.CO.UK
Name Server: NS-466.AWSDNS-58.COM
Name Server: NS-899.AWSDNS-48.NET
REGISTRAR Contact: DreamHost, LLC
>>> Last update of RDAP database: 2026-02-16T16:54:30Z         

			User-agent: imagesift
Disallow: /
User-agent: *
Allow: /
Sitemap: https://synapse.patsnap.com/sitemap.xml
        

テクニカルSEO

オンページSEO

コンテンツとUX